Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Atopic Dermatitis in Childhood

被引：2
|
作者：
Oh, J. [1 ]
Kim, J. [1 ]
Baik, H. [1 ]
Lee, H. [1 ]
机构：
[1] Hanyang Univ, Guri Hosp, Kyonggi Do, South Korea
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2011年 / 127卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2010.12.154
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB36 / AB36
页数：1
相关论文
共 50 条
  • [21] The clinical experience of intravenous immunoglobulin in severe atopic dermatitis
    Lee, J-H
    Kang, H-J
    Jwa, H-J
    ALLERGY, 2015, 70 : 588 - 589
  • [22] A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
    Dong Hyek Jang
    Seok Jae Heo
    Hyung Don Kook
    Dong Heon Lee
    Hye Jung Jung
    Mi Yeon Park
    Jiyoung Ahn
    Scientific Reports, 11
  • [23] Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study
    Guedon, C.
    Tauber, M.
    Linder, C.
    Paul, C.
    Shourick, J.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (03): : 215 - 216
  • [24] A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
    Jang, Dong Hyek
    Heo, Seok Jae
    Kook, Hyung Don
    Lee, Dong Heon
    Jung, Hye Jung
    Park, Mi Yeon
    Ahn, Jiyoung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [25] Efficacy of dupilumab in moderate and severe atopic dermatitis
    Weidinger, Stephan
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Schmitt, Jochen
    Leshem, Yael A.
    Katoh, Norito
    Chen, Zhen
    Zhang, Haixin
    Shumel, Brad
    Bansal, Ashish
    Chao, Jingdong
    Lu, Yufang
    Rossi, Ana B.
    Abramova, Alvina
    JEADV CLINICAL PRACTICE, 2023, 2 (02): : 247 - 260
  • [26] Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: Long-Term Changes of Clinical Severity and Laboratory Parameters
    Nahm, Dong-Ho
    Ahn, Areum
    Kim, Myoung-Eun
    Cho, Su-Mi
    Park, Mi Jung
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2016, 8 (04) : 375 - 382
  • [27] Long-term Treatment of Severe Recalcitrant Atopic Dermatitis with Omalizumab, an Anti-immunoglobulin E
    Quist, Sven R.
    Ambach, Andreas
    Goeppner, Daniela
    Quist, Jennifer
    Franke, Ingolf
    Bonnekoh, Bernd
    Gollnick, Harald P. M.
    ACTA DERMATO-VENEREOLOGICA, 2013, 93 (02) : 206 - 208
  • [28] Long-term efficacy and safety of intravenous injection of clonal mesenchymal stem cells derived from bone marrow in five adults with moderate to severe atopic dermatitis
    Shin, Hyun-Tae
    Lee, Si Hyub
    Yoon, Hee Seong
    Heo, Ji Hye
    Lee, Seon Bok
    Byun, Ji Won
    Shin, Jeonghyun
    Cho, Yun-Kyoung
    Chung, Eunkyung
    Jeon, Myung-Shin
    Song, Sun U.
    Choi, Gwang Seong
    JOURNAL OF DERMATOLOGY, 2021, 48 (08): : 1236 - 1242
  • [29] Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Hong, H. Chih-ho
    Peris, Ketty
    Katoh, Norito
    Tauber, Marie
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 30 - 31
  • [30] Assessment of long-term safety and efficacy of Dupilumab therapy in patients with moderate-to-severe atopic dermatitis in the UAE: A real-life observational study
    Abdulwahhab, Waqas S.
    Zainalabdin, Sham
    Al-Areqi, Noor
    Amrane, Imene
    Alhashmi, Ahmed
    Aburuz, Omar
    Akour, Amal
    Beiram, Rami
    Aburuz, Salahdein
    PHARMACY PRACTICE-GRANADA, 2024, 22 (02):
12345